Skip to main content

A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Completed · Phase 2 · NCT06074562

Conditions: Diabetic Peripheral Neuropathy

At a glance

Research payments reported, 2025
$1.3M
U.S. investigators named
34
Sites paid
40
Planned or actual enrollment
404

About the trial

Sponsor
Eli Lilly and Company
Tested
Mazisotine (drug), Placebo (drug)
Dates
Started 2023-10-05; completion 2025-06-11
Results posted
Yes

The main purpose of this study is to determine the safety and efficacy of LY3556050 versus placebo in participants with diabetic peripheral neuropathic pain (DPNP). The study will lasts approximately 24 weeks, across 3 study periods.

From ClinicalTrials.gov, last updated 2026-07-30. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $1.3M in research payments for this study in 2025 (72 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Elligo Health Research Inc $209,147
  • Northwest Clinical Research Center $147,139
  • Suncoast Research $125,294
  • New Horizon Research Center $117,826
  • Northwestern University $107,730
  • Juno Research LLC $97,433
  • Headlands Horizons LLC $67,654
  • Studymetrix Research LLC $54,791
  • Cmr of Greater New Haven LLC $51,937
  • Care Access Research LLC $48,065
  • Futuresearch Trials of Neurology LP $45,022
  • Velocity Clinical Research Inc $37,212
  • Valley Clinical Trials Inc $29,578
  • Irst Business Specialty Finance $24,916
  • Consano Clinical Research LLC $24,746
  • Northern California Research Corporation $22,700
  • Medvadis Research Corp LLC $21,150
  • Baptist Health $17,848
  • Lucas Research Inc $17,616
  • Clinvest Headlands LLC $13,078
  • True North Med at N Suffolk Pplc $9,921
  • Suburban Research Associates $8,784
  • New Phase Research & Development LLC $7,146
  • Sky Clinical Research Network Group $7,130
  • Alliance for Multispecialty Research Lls $5,763
  • Rainier Clinical Research Center $4,945
  • Institute for Liver Health LLC $4,267
  • Unimed Center $2,227
  • Suncoast Clinical Research $1,480
  • Clinical Trial Source LLC $1,150
  • Las Vegas Medical Research LLC $965
  • Diabetes and Endocrinology Consultants $825
  • The Center for Pharmaceutical Research PC $635
  • North Suffolk Neurology $576
  • Future Search Trials of Dallas LP $563
  • Radiant Research Inc $406
  • Clinvest Research LLC $195
  • Mehrdad Kevin Ariani MD $195
  • Rainier Clinical Research Center Inc $174
  • $31
  • Clinical Trials of Swla LLC $2

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.